SOLESENCE, INC. — Director's Dealing 2020

Oct 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2020-10-28

Reporting Person: Beres Laura M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-28	Common Stock	$0.62	A	10000	Acquired	2027-10-28	Common Stock (10000)	Direct

Footnotes

F1: Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments.